Loading...
•
Sep 30
Outset Medical Q3 2025 Earnings Report
Outset Medical reported its Q3 2025 earnings, with revenue reaching $36.2 million and a net loss of $23.1 million.
Key Takeaways
Outset Medical's third quarter of 2025 saw a revenue of $36.2 million, a 10% increase year-over-year, driven by strong product revenue. Despite the revenue growth, the company reported a net loss of $23.1 million and a non-GAAP net loss of $18.5 million. Gross margin improved to 25.4%, and the Tablo installed base grew to 4,000 units.
Revenue for Q3 2025 increased by 10% year-over-year to $36.2 million.
The company reported a net loss of $23.1 million and a non-GAAP net loss of $18.5 million.
Gross margin improved to 25.4%, up from 20.1% in the prior year period.
The Tablo installed base expanded to 4,000 units, marking a 25% increase year-over-year.
Outset Medical
Outset Medical
Outset Medical Revenue by Segment
Revenue by Segment
Product Revenue
CapyFin.comService and Other Revenue
CapyFin.com Forward Guidance
Outset Medical provided updated full-year 2025 guidance, projecting revenue between $140 million and $145 million, and a non-GAAP net loss between $75 million and $80 million. The company expects continued growth in its Tablo installed base and recurring revenue.
Positive Outlook
- Full-year 2025 revenue guidance of $140 million to $145 million, indicating continued growth.
- Anticipated expansion of the Tablo installed base, driving future recurring revenue.
- Expected improvement in gross margin for the full year.
- Focus on operational efficiency to reduce non-GAAP net loss.
- Strong market demand for Tablo Hemodialysis System.
Challenges Ahead
- Continued non-GAAP net loss projected for the full year 2025, ranging from $75 million to $80 million.
- Uncertainties in the broader economic environment could impact healthcare spending.
- Potential for increased competition in the dialysis market.
- Supply chain disruptions could affect product availability and cost.
- Regulatory changes in healthcare could impact market access and reimbursement.
Revenue & Expenses
Visualization of income flow from segment revenue to net income